<?xml version="1.0" encoding="UTF-8"?>
<p>Importantly, treatment did not amplify either the post‐surgical immune‐depression observed in the placebo group (illustrated by the strongly reduced monocytic HLA‐DR expression; 
 <italic>Figure</italic>
 <xref rid="jcsm12316-fig-0006" ref-type="fig">6</xref>A) or post‐operative systemic inflammation [as in IL‐6 (
 <italic>Figure</italic>
 <xref rid="jcsm12316-fig-0006" ref-type="fig">6</xref>B) or CrP plasma levels]. 
 <list list-type="roman-lower" continued-from="jcsm12316-list-0001" id="jcsm12316-list-0002">
  <list-item id="jcsm12316-li-0002">
   <p>Can the clear dose‐dependent differences in efficacy and its kinetics be related to a differential immunomodulation by the PLX‐PAD cells?</p>
  </list-item>
 </list>
</p>
